Our study shows that ABCG5/8 could be underestimated in pediatric patients with hypercholesterolemia and NGS has an advantage in diagnosing sitosterolemia or carriers of ABCG5/8 gene comparing to gene panels of FH. This evidence concerns the gene ABCG5 and sitosterolemia.